Innoviva, Inc. — Director's Dealing 2013

Jul 27, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2013-07-24

Reporting Person: Mammen Mathai (SVP, Research & Early Clin Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-24	Common Stock	A	5000	—	Acquired	218705	Direct

Footnotes

F1: On February 7, 2013, the reporting person was granted a performance stock award (PSA) covering 5,000 shares of common stock. The PSA vests over approximately four years of service from the grant date, contingent upon the achievement of one of three possible performance goals. Upon the achievement of one of the performance goals on July 24, 2013, the PSA began vesting.